Australia says CSL unit Seqirus to discontinue Benpen injections from November

Australia's drug regulator ​said on Wednesday ‌it was notified by ​biopharmaceutical ​giant CSL's unit Seqirus ⁠that ​it will be ​discontinuing all strengths of their ​Benpen injection ​products progressively due ‌to ⁠commercial reasons.